Roflumilast in Non-CF Bronchiectasis Study (2019)
NCT04322929
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Non-cystic Fibrosis Bronchiectasis
Interventions
DRUG:
Roflumilast Oral Tablet
Sponsor
The University of Hong Kong